Kobe University · Graduate School of Medicine / Faculty of Medicine

Research keywordsRor signaling・Wnt signaling・ferroptosis・lung adenocarcinoma・beta-cell aging・glioma stem cells・Nrf2 signaling

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP12025 · Elsevier BV, 2025年05月, Cell, 188(10) (10), 2569 - 2585.e20, 英語
• Rho family small GTPase Rif regulates Wnt5a-Ror1-Dvl2 signaling and promotes lung adenocarcinoma progression2023 · Elsevier BV, 2023年09月, Journal of Biological Chemistry, 299(10) (10), 105248 - 105248, 英語
• Wnt 2022 EMBO | the Company of Biologists workshop and Yamada conference.2022 · Wnt2022 was held on November 15th-19th, 2022, in Awaji Yumebutai International Conference Center, Hyogo Prefecture, Japan, as an in-person meeting for the first time in last 3 years. Wnt signaling is a highly conserved pathway among various species. Since Wnt1 was discovered in 1982, a number of studies using many model animals and human samples have revealed that Wnt signaling plays crucial roles in embryonic development, tissue morphogenesis, and regeneration, as well as many other physiological and pathological processes. Since the year 2022 marks the 40th anniversary of Wnt research, we aimed to look back at our research progress and discuss the future direction of this field. The scientific program consisted of plenary lectures, invited talks, short talks selected from abstracts, and poster sessions. Whereas several different Wnt meetings have been held almost every year in Europe and the United States, this was the first Wnt meeting convened in Asia. Therefore, Wnt2022 was highly anticipated to bring together leaders and young scientists from Europe, the United States, and especially Asia and Oceania. In fact, 148 researchers from 21 countries attended this meeting. Although there were travel and administrative restrictions due to COVID-19, the meeting was highly successful in enabling face-to-face discussions.
• Increased glycolysis affects β-cell function and identity in aging and diabetes2022 · Elsevier BV, 2022年01月, Molecular Metabolism, 55, 101414 - 101414, 英語

• 膵がん治療のためのRhoファミリーGTPaseとその共役分子阻害剤の検証 南 康博 日本医療研究開発機構, 創薬ブースター（創薬支援ネットワーク）, 神戸大学大学院医学研究科, 2025年04月 - 2026年03月, 研究代表者2025 · KUID parsed section
• 卵巣癌の腟分泌物抽出miRNAによる早期診断と人工エクソソームを用いた核酸治療開発 寺井 義人, 高橋 良輔, 笹川 勇樹, 出口 雅士, 長又 哲史, 犬伏 祥子, 竹内 俊文, 南 康博, 谷村 憲司, 若橋 宣, 遠藤 光晴 日本学術振興会, 科学研究費助成事業, 基盤研究(C), 神戸大学, 2024年04月 - 2027年03月2024 · KUID parsed section
• 老化研究支援・推進に関する研究開発 南 康博 日本医療研究開発機構, 革新的先端研究開発支援事業, AMED-CREST, 神戸大学大学院医学研究科, 2022年10月 - 2030年03月, 研究代表者2022 · KUID parsed section
• (AMED)老化機構・制御研究拠点/加齢に伴う細胞形態・運動制御の異常の分子機構 南 康博 国立大学法人大阪大学, 老化メカニズムの解明・制御プロジェクト, 2017年, 研究代表者 競争的資金2017 · KUID parsed section

• Official profile